Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4915802

COc1ccc(-c2nnc(-c3cccnc3)o2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.76
RAB9A P51151 8/20 0.76
KDM4E B2RXH2 6/20 0.76
ALDH1A1 P00352 4/20 0.76
SMN1; SMN2 Q16637 3/20 0.76
HPGD P15428 3/20 0.76
CYP2C19 P33261 2/20 0.76
CYP1A2 P05177 1/20 0.76
CYP3A4 P08684 1/20 0.76
MAPK1 P28482 2/20 0.54
HSD17B10 Q99714 2/20 0.54
GAA P10253 1/20 0.54
USP2 O75604 1/20 0.52
MAPT P10636 2/20 0.51
KMT2A Q03164 2/20 0.51
POLB P06746 1/20 0.51
HTT P42858 1/20 0.51
LMNA P02545 1/20 0.50
MEN1 O00255 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3629214 0.89 KDM4E (0.61) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3634061 0.88 KDM4E (0.58) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4927268 0.88 NPC1 (0.57) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3635099 0.87 NPC1 (0.61) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3635392 0.87 NPC1 (0.57) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL1423243 0.87 NPC1 (1.00) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4927459 0.86 NPC1 (0.74) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3630559 0.86 KDM4E (0.56) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3627583 0.86 KDM4E (0.56) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3633226 0.85 NPC1 (0.58) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE CYP11B2, AADAC, CYP11B1 NPC1 473/4885RAB9A 3859/4885KDM4E 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.